Anti-RPS6KB2 monoclonal antibody

Pre-made anti-RPS6KB2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RPS6KB2/RPS6KB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T42760-Ab-1/ GM-Tg-hg-T42760-Ab-2Anti-Human RPS6KB2 monoclonal antibodyHuman
GM-Tg-rg-T42760-Ab-1/ GM-Tg-rg-T42760-Ab-2Anti-Rat RPS6KB2 monoclonal antibodyRat
GM-Tg-mg-T42760-Ab-1/ GM-Tg-mg-T42760-Ab-2Anti-Mouse RPS6KB2 monoclonal antibodyMouse
GM-Tg-cynog-T42760-Ab-1/ GM-Tg-cynog-T42760-Ab-2Anti-Cynomolgus/ Rhesus macaque RPS6KB2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T42760-Ab-1/ GM-Tg-felg-T42760-Ab-2Anti-Feline RPS6KB2 monoclonal antibodyFeline
GM-Tg-cang-T42760-Ab-1/ GM-Tg-cang-T42760-Ab-2Anti-Canine RPS6KB2 monoclonal antibodyCanine
GM-Tg-bovg-T42760-Ab-1/ GM-Tg-bovg-T42760-Ab-2Anti-Bovine RPS6KB2 monoclonal antibodyBovine
GM-Tg-equg-T42760-Ab-1/ GM-Tg-equg-T42760-Ab-2Anti-Equine RPS6KB2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T42760-Ab-1/ GM-Tg-hg-T42760-Ab-2; GM-Tg-rg-T42760-Ab-1/ GM-Tg-rg-T42760-Ab-2;
GM-Tg-mg-T42760-Ab-1/ GM-Tg-mg-T42760-Ab-2; GM-Tg-cynog-T42760-Ab-1/ GM-Tg-cynog-T42760-Ab-2;
GM-Tg-felg-T42760-Ab-1/ GM-Tg-felg-T42760-Ab-2; GM-Tg-cang-T42760-Ab-1/ GM-Tg-cang-T42760-Ab-2;
GM-Tg-bovg-T42760-Ab-1/ GM-Tg-bovg-T42760-Ab-2; GM-Tg-equg-T42760-Ab-1/ GM-Tg-equg-T42760-Ab-2
Products NameAnti-RPS6KB2 monoclonal antibody
Formatmab
Target NameRPS6KB2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RPS6KB2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T42760-Ag-1Recombinant multi-species KS6B2/ RPS6KB2/ KLS protein


    Target information

    Target IDGM-T42760
    Target NameRPS6KB2
    Gene ID6199,58988,361696,721731,610499,101091812,506083,100053005
    Gene Symbol and SynonymsKLS,p70(S6K)-beta,P70-beta,P70-beta-1,P70-beta-2,p70S6Kb,RPS6KB2,S6K-beta-2,S6K-beta2,S6K2,S6KB,S6Kbeta,S6KI(2),SRK,STK14B
    Uniprot AccessionQ9UBS0
    Uniprot Entry NameKS6B2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000175634
    Target ClassificationN/A

    The target: RPS6KB2, gene name: RPS6KB2, also named as KLS, P70-beta, P70-beta-1, P70-beta-2, S6K-beta2, S6K2, S6KB, S6KI(2), S6Kbeta, SRK, STK14B, p70(S6K)-beta, p70S6Kb. This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains a kinase catalytic domain and phosphorylates the S6 ribosomal protein and eukaryotic translation initiation factor 4B (eIF4B). Phosphorylation of S6 leads to an increase in protein synthesis and cell proliferation. [provided by RefSeq, Jan 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.